Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 300
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT02664935 | National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer | ||
| NCT01800071 | A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma | ||
| NCT03797443 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | ||
| NCT01785992 | A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. | ||
| NCT03024580 | A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | ||
| NCT02874729 | Assay Development for Cancer Biomarkers | ||
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | ||
| NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT05615818 | Personalized Medicine for Advanced Biliary Cancer Patients | ||
| NCT03424668 | The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study | ||
| NCT03432429 | Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT06086574 | Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer | ||
| NCT01590160 | Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT02866370 | Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium | ||
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT06447064 | Cancer Loyalty Card Study 2 (CLOCS-2) | ||
| NCT02933320 | BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia | ||
| NCT05537844 | Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma | ||
| NCT03486730 | BT1718 in Patients with Advanced Solid Tumours. | ||
| NCT05541601 | Prospective Cohort for Early Detection of Liver Cancer | ||
| NCT01098344 | MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | ||
| NCT02330926 | Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy | ||
| NCT01888601 | TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx) | ||
| NCT03908333 | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | ||
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | ||
| NCT00595777 | Edinburgh Pain Assessment Tool (EPAT©) Study | ||
| NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | ||
| NCT01551459 | A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma | ||
| NCT02170090 | Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer | ||
| NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT05408169 | Increasing Uptake of Bowel Screening | ||
| NCT03410030 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | ||
| NCT03741426 | WIRE - Novel Treatments in Renal Cell Cancer | ||
| NCT00134108 | Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients | ||
| NCT01160926 | Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial | ||
| NCT02308527 | Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children | ||
| NCT00427713 | Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer | ||
| NCT07279454 | The EAT-FIBRE Study. | ||
| NCT04226937 | DLBCL Interim Response Evaluation for Customised Therapy | ||
| NCT00532194 | An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer | ||
| NCT05047107 | Biology and Genetics of Smouldering Myeloma |
